Trina L. Jashinsky
CIK 1638336 · View on SEC EDGAR ↗
First SEC filing: March 6, 2018 · Latest: March 6, 2018
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 6, 2020 | BMI | A | 588 | — | — | 2,479 Direct | +31.09% | Acquired | (price as of 2026-08-20) |
| March 6, 2020 | BMI | A | 2,144 | — | — | 2,144 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 23, 2020 | BMI | A | 82 | $64.93 | $5,324 | 287 Indirect | +40.00% | Acquired | 101.4% (price as of 2026-08-20) |
| March 1, 2019 | BMI | A | 1,648 | — | — | 1,648 Direct | — | Acquired | (price as of 2026-08-20) |
| March 1, 2019 | BMI | A | 498 | — | — | 1,891 Direct | +35.75% | Acquired | (price as of 2026-08-20) |
| Jan. 25, 2019 | BMI | A | 107 | $49.21 | $5,265 | 205 Indirect | +109.18% | Acquired | 165.8% (price as of 2026-08-20) |
| March 2, 2018 | BMI | A | 610 | — | — | 1,393 Direct | +77.91% | Acquired | (price as of 2026-08-20) |
| March 2, 2018 | BMI | A | 1,621 | — | — | 1,621 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 30, 2018 | BMI | A | 98 | $47.80 | $4,684 | 98 Indirect | — | Acquired | 173.6% (price as of 2026-08-20) |
| March 3, 2017 | BMI | A | 783 | — | — | 783 Indirect | — | Acquired | (price as of 2026-08-20) |
| March 3, 2017 | BMI | A | 6,981 | — | — | 6,981 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 6, 2020 | BMI | Stock Options | BMI Common Stock (2,144) | $63.04 | March 6, 2030 | 2,144 | Acquired |
| March 1, 2019 | BMI | Stock Options | BMI Common Stock (1,648) | $59.85 | March 1, 2029 | 1,648 | Acquired |
| March 2, 2018 | BMI | Stock Options | BMI Common Stock (1,621) | $48.20 | March 2, 2028 | 1,621 | Acquired |
| March 3, 2017 | BMI | Stock Options | BMI Common Stock (6,981) | $36.45 | March 3, 2027 | 6,981 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $215,300 | $58,023 | $29,805 | $29,994 | — | $130 | $32,626 | $402,503 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.